International Journal of Clinical Pediatric Dentistry

Register      Login

VOLUME 14 , ISSUE 2 ( March-April, 2021 ) > List of Articles


Isolated Focal Infantile Hemangioma of the Alveolar Ridge with Glucose Transporter-1 Reactivity: An Aberrant Presentation

Divya Natarajan, Shanmugam Muthukali, Nachiammai Nachiappan, Joe Louis Chiriyamkandath, Jayanthi Kannappan

Keywords : Alveolar ridge, Benign tumor, Glucose transporter-1, Hemangioma, Infant, Infantile hemangioma, Oral pathology, Vascular tumor

Citation Information : Natarajan D, Muthukali S, Nachiappan N, Chiriyamkandath JL, Kannappan J. Isolated Focal Infantile Hemangioma of the Alveolar Ridge with Glucose Transporter-1 Reactivity: An Aberrant Presentation. Int J Clin Pediatr Dent 2021; 14 (2):319-322.

DOI: 10.5005/jp-journals-10005-1923

License: CC BY-NC 4.0

Published Online: 30-07-2021

Copyright Statement:  Copyright © 2021; The Author(s).


Aim and objective: To give dental practitioners an insight into the unusual presentation of focal infantile hemangioma on the alveolar ridge showing immunoreactivity to glucose transporter-1 (GLT1). We also recommend the importance of using standardized terminologies to describe the type of hemangioma. Background: One of the most commonly seen and misdiagnosed vascular tumors of the skin and soft tissues of the head and neck region in children are infantile hemangiomas. Infantile hemangiomas developing at extracutaneous locations such as the oral cavity are rare, especially without cutaneous involvement. Case description: A 9-month-old infant girl presented to the Pediatric Dental Department with a swelling over the maxillary alveolar ridge. The solitary exophytic mass appeared after birth and gradually enlarged in size with episodes of bleeding during feeding. Clinical examination revealed a reddish-pink pedunculated mass that bled profusely on palpation. The lesion was excised by electrocautery and was found to be express glucose transporter-1 confirming the diagnosis of infantile hemangioma. The patient was followed up for 1 year and showed no recurrence. Conclusion: Hemangiomas are usually misinterpreted to be pyogenic granulomas, vascular malformation, reactive granulation tissue, or congenital granular cell tumor. This report highlights the use of glucose transporter-1 when there is suspicion of hemangioma for immunohistochemical distinction from other histologically similar vascular lesions of the oral cavity. Clinical significance: Dental surgeons treating vascular lesions of the oral cavity should advocate for surgical management techniques that also produce hemostasis due to the risk of intraoperative bleeding.

  1. Winer LH. Hemangiomas; histologic structure, and treatment. Calif Med 1952;77(4):242–247.
  2. Corrêa PH, Nunes LC, Johann AC, et al. Prevalence of oral hemangioma, vascular malformation and varix in a Brazilian population. Braz Oral Res 2007;21(1):40–45. DOI: 10.1590/s1806-83242007000100007.
  3. Fočo F, Brkić A. Vascular anomalies of the maxillofacial region: Diagnosis and management. In: Motamedi MHK, ed. A Textbook of advanced oral and maxillofacial surgery. Rijeka: IntechOpen; 2013. pp. 303–323. [cited 2020 Aug 05]. Available from:
  4. Nanda VS. Management of capillary hemangiomas. West J Med 1994;160(4):364.
  5. Amir J, Metzker A, Krikler R, et al. Strawberry hemangioma in preterm infants. Pediatr Dermatol 1986;3(4):331–332. DOI: 10.1111/j.1525-1470.1986.tb00535.x.
  6. Mulliken JB, Burrows PE, Fishman SJ. Mulliken and Young's vascular anomalies: hemangiomas and malformations. 2nd ed., Oxford: Oxford University Press; 2013. pp. 22–110.
  7. Sahin G, Duzcan-Kilimci D, Tanyildiz HG. Epidemiological features and risks of hemangiomas. Turk J Pediatr 2017;59(6):664–669. DOI: 10.24953/turkjped.2017.06.007.
  8. Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 1983;18(6):894–900. DOI: 10.1016/s0022-3468(83)80043-8.
  9. Acikgoz A, Sakallioglu U, Ozdamar S, et al. Rare benign tumours of oral cavity--capillary haemangioma of palatal mucosa: a case report. Int J Paediatr Dent 2000;10(2):161–165. DOI: 10.1046/j.1365-263x.2000.00188.x.
  10. Bonet-Coloma C, Minguez-Martinez I, Palma-Carrio C, et al. Clinical characteristics, treatment and outcome of 28 oral haemangiomas in pediatric patients. Med Oral Patol Oral Cir Bucal 2011;16(1):e19–e22. DOI: 10.4317/medoral.16.e19.
  11. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69(3):412–422. DOI: 10.1097/00006534-198203000-00002.
  12. ISSVA Classification of Vascular Anomalies [Internet]. Milwaukee: International Society for the Study of Vascular Anomalies; 2018 [cited 2020 Aug 05]. Available at:
  13. Hassanein AH, Mulliken JB, Fishman SJ, et al. Evaluation of terminology for vascular anomalies in current literature. Plast Reconstr Surg 2011;127(1):347–351. DOI: 10.1097/PRS.0b013e3181f95b83.
  14. Waner M, North PE, Scherer KA, et al. The nonrandom distribution of facial hemangiomas. Arch Dermatol 2003;139(7):869–875. DOI: 10.1001/archderm.139.7.869.
  15. Thomas MW, Burkhart CN, Vaghani SP, et al. Failure to thrive in infants with complicated facial hemangiomas. Pediatr Dermatol 2012;29(1):49–52. DOI: 10.1111/j.1525-1470.2011.01400.x.
  16. North PE, Waner M, Mizeracki A, et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000;31(1):11–22. DOI: 10.1016/s0046-8177(00)80192-6.
  17. Leon-Villapalos J, Wolfe K, Kangesu L. GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plast Surg 2005;58(3):348–352. DOI: 10.1016/j.bjps.2004. 05.029.
  18. Huang L, Nakayama H, Klagsbrun M, et al. Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit features of facultative stem cells. Stem Cells 2015;33(1):133–145. DOI: 10.1002/stem.1841.
  19. de Oliveira DH, da Silveira EJ, de Medeiros AM, et al. Study of the etiopathogenesis and differential diagnosis of oral vascular lesions by immunoexpression of GLUT-1 and HIF-1alpha. J Oral Pathol Med 2014;43(1):76–80. DOI: 10.1111/jop.12092.
  20. Johann AC, Salla JT, Gomez RS, et al. GLUT-1 in oral benign vascular lesions. Oral Dis 2007;13(1):51–55. DOI: 10.1111/j.1601-0825.2006.01246.x.
  21. Dyduch G, Okon K, Mierzynski W. Benign vascular proliferations-an immunohistochemical and comparative study. Pol J Pathol 2004;55(2):59–64.
  22. Drut RM, Drut R. Extracutaneous infantile haemangioma is also Glut1 positive. J Clin Pathol 2004;57(11):1197–1200. DOI: 10.1136/jcp.2003.012682.
  23. North PE, Waner M, Mizeracki A, et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 2001;137(5):559–570.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.